Navigation Links
febit Forms Scientific Advisory Board
Date:3/31/2008

Five renowned researchers to guide febit's research and business

development activities

MEDFORD, Mass. and HEIDELBERG, Germany, March 31 /PRNewswire/ -- febit group, the provider of the unique microfluidic microarray system Geniom, today announced the formation of a Scientific Advisory Board (SAB) consisting of leading authorities at the forefront of genetics and genomics research. The SAB members, from top research institutions and companies, will provide expert advice on febit's research and development activities associated with its portfolio development.
The interdisciplinary febit Scientific Advisory Board consists of:

-- Mark Chee, Ph.D., who will serve as chairman. As a former scientist of

Affymetrix and co-founder of Illumina (ILMN) he has an exceptional

knowledge of microarray technologies and market.

-- Karoly Nikolich, Ph.D., who will serve as vice chairman. Dr. Nikolich

was formerly the executive director of the Neuroscience Institute of

Stanford. He is an entrepreneur and consultant, and has over 20 years

of biotechnology industry experience in R&D.

-- David Lockhart, Ph.D., the CSO of Amicus Therapeutics. Dr. Lockhart

brings many years of industry experience and achievements, including

credit as the primary inventor and developer of genome-wide

gene-expression profiling with high-density DNA arrays when he was at

Affymetrix.

-- Mostafa Ronaghi, Ph.D., one of the inventors of Pyrosequencing,

molecular inversion probe assay and Nextbio search engine. He has

co-founded four companies and serves on the board of director and

scientific advisory board of several companies.

-- Jeffrey Trent, Ph.D., the president and scientific director of the

Translational Genomics Research Institute (TGen) in Phoenix, Ariz. In

addition to his expertise in cDNA-microarray, Dr. Trent was one of the

leading scientists with the "Human Genome Project."

"The formation of febit's scientific advisory board brings together key thought leaders with deep insight into the needs of the scientific community in genomic research," said Cord F. Staehler, CEO of febit holding gmbh. "We look forward to their support and guidance that will help us realize the full potential of febit's portfolio of unique applications for existing and future strategic partnerships."

Dr. Chee added, "It is our goal to help febit meet scientists' needs and open up new possibilities in genomic research. febit's Geniom technology is a unique tool for various applications in this field from microarray analysis to synthetic biology."

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications. http://www.febit.com

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
2. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
3. Technology Transforms Market Research in Pharmaceutical Industry
4. Anthera Pharmaceuticals Forms Scientific Advisory Board
5. Transgenomic, Inc. Forms Scientific Advisory Board
6. ADM Forms Industrial Chemicals Group
7. iGuard Transforms Drug Safety Alert and Update Process
8. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
9. NASA technology forms the basis for a new nanotechnology company
10. Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
11. Boston Scientific Announces Schedule for ACC 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... YORK , Feb. 23, 2017 ... digital health company, and Digital Noema Telehealth ... remote patient monitoring, announce they are partnering to ... DN Telehealth maximizes collaboration compatibility for its ... beyond a physical clinical setting to include fully ...
(Date:2/23/2017)... ATLANTA , Feb. 23, 2017  In Atlanta, it ... art, fashion, and culture intertwine to create an expressive and ... often reflect this energy and contribute to it. ... , Hair Fairies seeks to carry on that ... The Atlanta salon is the newest ...
(Date:2/23/2017)... INDIANAPOLIS, Ind. (PRWEB) , ... February 23, 2017 ... ... Commercialization Award during the 12th annual Inventors Recognition Reception at Purdue Research ... annually to a faculty member in recognition of outstanding contributions to, and success ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/2/2017)...  EyeLock LLC, a market leader of iris-based identity ... What You Should Know About Biometrics in the Cloud ... is a growing concern. In traditional schemes, cryptography is ... authentication schemes such as username/password suffer from inherent weaknesses. ... an elegant solution to the problem of high-security user ...
Breaking Biology News(10 mins):